Online citations, reference lists, and bibliographies.
← Back to Search

In Vivo Tumor Targeting And Image-guided Drug Delivery With Antibody-conjugated, Radiolabeled Mesoporous Silica Nanoparticles.

F. Chen, Hao Hong, Yin Zhang, H. Valdovinos, Sixiang Shi, G. Kwon, C. Theuer, T. Barnhart, W. Cai
Published 2013 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Since the first use of biocompatible mesoporous silica (mSiO2) nanoparticles as drug delivery vehicles, in vivo tumor targeted imaging and enhanced anticancer drug delivery has remained a major challenge. In this work, we describe the development of functionalized mSiO2 nanoparticles for actively targeted positron emission tomography (PET) imaging and drug delivery in 4T1 murine breast tumor-bearing mice. Our structural design involves the synthesis, surface functionalization with thiol groups, PEGylation, TRC105 antibody (specific for CD105/endoglin) conjugation, and (64)Cu-labeling of uniform 80 nm sized mSiO2 nanoparticles. Systematic in vivo tumor targeting studies clearly demonstrated that (64)Cu-NOTA-mSiO2-PEG-TRC105 could accumulate prominently at the 4T1 tumor site via both the enhanced permeability and retention effect and TRC105-mediated binding to tumor vasculature CD105. As a proof-of-concept, we also demonstrated successful enhanced tumor targeted delivery of doxorubicin (DOX) in 4T1 tumor-bearing mice after intravenous injection of DOX-loaded NOTA-mSiO2-PEG-TRC105, which holds great potential for future image-guided drug delivery and targeted cancer therapy.
This paper references
10.1016/j.biomaterials.2010.03.048
Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles.
Jeffrey S. Souris (2010)
10.1021/ar200090c
Monodisperse magnetic nanoparticles for theranostic applications.
Don N. Ho (2011)
10.1016/j.biomaterials.2011.12.030
Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging.
Yuling Xiao (2012)
10.1021/nn200809t
Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model.
Huan Meng (2011)
10.1002/chem.201103611
A uniform sub-50 nm-sized magnetic/upconversion fluorescent bimodal imaging agent capable of generating singlet oxygen by using a 980 nm laser.
Feng Chen (2012)
PET radiopharmaceuticals for probing enzymes in the brain.
J. Holland (2013)
10.1002/ADFM.201101663
Positive and negative lattice shielding effects co-existing in Gd (III) ion doped bifunctional upconversion nanoprobes
F. Chen (2011)
10.1021/ac801882g
In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles.
X. He (2008)
10.1016/J.NANTOD.2009.07.001
Molecular imaging and therapy of cancer with radiolabeled nanoparticles.
Hao Hong (2009)
10.1002/adma.201103343
Targeting gold nanoshells on silica nanorattles: a drug cocktail to fight breast tumors via a single irradiation with near-infrared laser light.
H. Liu (2012)
HaloTag as a reporter gene: positron emission tomography imaging with (64)Cu-labeled second generation HaloTag ligands.
Hao Hong (2013)
10.1002/smll.201002300
Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells.
D. Ferris (2011)
10.1021/ja211035w
Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles.
Limin Pan (2012)
10.1016/j.biomaterials.2012.02.031
In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene.
Hao Hong (2012)
10.1039/B907978E
An efficient cell-targeting and intracellular controlled-release drug delivery system based on MSN-PEM-aptamer conjugates
C. Zhu (2009)
10.1021/ar200231d
Theranostic nanomedicine.
X. Chen (2011)
10.2217/nnm.11.79
In vivo biodistribution of nanoparticles.
Joao Paulo Mattos Almeida (2011)
10.1158/1078-0432.CCR-07-4478
Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy
N. Dallas (2008)
10.1038/NM0195-27
Angiogenesis in cancer, vascular, rheumatoid and other disease
J. Folkman (1995)
10.1039/B905158A
Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells
Chih-Pin Tsai (2009)
10.1021/nn901146y
In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.
R. Kumar (2010)
Molecular imaging probe development: a chemistry perspective.
Donald D. Nolting (2012)
Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab.
Yin Zhang (2012)
10.1021/ja905793q
Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery.
J. Lee (2010)
10.2174/156720111793663570
Endoglin-targeted cancer therapy.
B. Seon (2011)
10.1021/nn204625e
In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene.
Hao Hong (2012)
10.1002/smll.201000538
Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.
J. Lu (2010)
10.1038/nrd2614
Nanoparticle therapeutics: an emerging treatment modality for cancer
M. Davis (2008)
10.1021/ar3000986
Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
Derrick Tarn (2013)
10.1021/ar200061q
Gold nanocages: from synthesis to theranostic applications.
Y. Xia (2011)
10.1039/c2cs15308d
Functionalized mesoporous silica materials for controlled drug delivery.
P. Yang (2012)
10.1007/s00259-011-1765-5
Positron emission tomography imaging of CD105 expression during tumor angiogenesis
Hao Hong (2011)
10.1002/CHIN.201320278
Nano-Graphene in Biomedicine: Theranostic Applications
K. Yang (2013)
10.1093/cvr/cvp332
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours.
E. Fonsatti (2010)
10.1016/j.biomaterials.2013.01.047
Tumor vasculature targeting and imaging in living mice with reduced graphene oxide.
Sixiang Shi (2013)
10.1021/ar2000259
Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
J. Lee (2011)
10.1038/nrc1093
Angiogenesis: Tumorigenesis and the angiogenic switch
G. Bergers (2003)
10.1007/s00259-011-1930-x
Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105
Hao Hong (2011)
10.1158/1078-0432.CCR-12-0098
A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer
L. Rosen (2012)
10.1016/j.biomaterials.2012.12.043
The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes.
Changhui Fu (2013)
10.1016/j.nano.2011.06.002
In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification.
J. Lu (2012)
10.1021/mp400044j
Theranostic nanomedicine with functional nanoarchitecture.
D. Pan (2013)
10.7150/thno.4156
Nano-Carbons as Theranostics
Zhuang Liu (2012)
Multimodality Imaging of Breast Cancer Experimental Lung Metastasis with Bioluminescence and a Monoclonal Antibody DualLabeled with 89
H. Hong (2012)
10.1021/nn800781r
Targeting of porous hybrid silica nanoparticles to cancer cells.
J. Rosenholm (2009)
10.1021/JP201053D
Preparation of pH-Responsive Mesoporous Silica Nanoparticles and Their Application in Controlled Drug Delivery
L. Yuan (2011)
10.1039/c2cs35342c
Nano-graphene in biomedicine: theranostic applications.
K. Yang (2013)
10.1002/anie.200802469
Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery.
J. Kim (2008)
10.1021/nn2043803
Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold.
T. Yu (2012)
10.1016/J.NANTOD.2012.10.010
Odyssey of a cancer nanoparticle: from injection site to site of action.
Joseph W. Nichols (2012)
10.1021/mp300277f
Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW.
Hao Hong (2012)



This paper is referenced by
10.1021/acsnano.7b08103
Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.
N. Lu (2018)
Development and characterization of targeted MART-1-nanoparticles for melanoma treatment and β-lapachone-loaded liposomal in hydrogel for wound healing
Sarah Brandão Palácio (2017)
10.1038/s41598-018-25878-8
Understanding the Connection between Nanoparticle Uptake and Cancer Treatment Efficacy using Mathematical Modeling
T. Brocato (2018)
10.1002/ADFM.201500610
Mechanically Tunable Hollow Silica Ultrathin Nanoshells for Ultrasound Contrast Agents.
Alex Liberman (2015)
Theranostic nanomedicine for cancer detection and treatment 5
Zhiping Fan ()
10.3390/molecules23112749
Selective Photokilling of Human Pancreatic Cancer Cells Using Cetuximab-Targeted Mesoporous Silica Nanoparticles for Delivery of Zinc Phthalocyanine
Özge Er (2018)
10.3390/nano9040511
Smart Mesoporous Silica Nanoparticles for Protein Delivery
Hai-jun Liu (2019)
10.1002/ADFM.201504810
FeSe2-Decorated Bi2Se3 Nanosheets Fabricated via Cation Exchange for Chelator-Free 64Cu-labeling and Multimodal Image-Guided Photothermal-Radiation Therapy.
Liang Cheng (2016)
10.2174/9781681080468115010004
Nanoparticles for Diagnostics and Imaging
M. Larguinho (2015)
10.7150/ntno.25119
Tumor Theranostics of Transition Metal Ions Loaded Polyaminopyrrole Nanoparticles
Shu-yao Li (2018)
10.1002/ADFM.201801738
Light‐Activatable Assembled Nanoparticles to Improve Tumor Penetration and Eradicate Metastasis in Triple Negative Breast Cancer
Jianfeng Ji (2018)
10.1021/nn507241v
In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine
F. Chen (2015)
10.1002/wnan.1560
Recent advances in photodynamic therapy for cancer and infectious diseases.
Xutong Shi (2019)
10.1039/C9NH00344D
A champagne inspired dual chain-responsive thrombolytic drug release platform based on black phosphorus nanosheets for accelerated thrombolysis
X. Ding (2019)
10.1038/nmat3877
A targeted approach to cancer imaging and therapy.
Chun Xing Li (2014)
10.3762/bjnano.10.16
Targeting strategies for improving the efficacy of nanomedicine in oncology
Gonzalo Villaverde (2019)
10.1016/j.biomaterials.2015.04.053
Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer.
Guangbao Yang (2015)
10.1021/acsbiomaterials.5b00420
Thiol-ene click hydrogels for therapeutic delivery.
Prathamesh M Kharkar (2016)
10.1117/1.JBO.20.8.088003
Quantification of endocytosis using a folate functionalized silica hollow nanoshell platform
S. Sandoval (2015)
10.1002/smll.201600325
Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.
Jing-jing Hu (2016)
10.1007/978-981-10-0063-8_9
Multifunctional Mesoporous/Hollow Silica for Cancer Nanotheranostics
H. Liu (2016)
10.2147/IJN.S179806
A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
I. Hajdú (2018)
10.1021/acs.bioconjchem.5b00399
Field Guide to Challenges and Opportunities in Antibody-Drug Conjugates for Chemists.
Mallory R Gordon (2015)
10.7150/thno.11742
Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines
M. Durymanov (2015)
10.1002/9781118942246.CH4.2
Hybrid Particles: Conjugation of Biomolecules to Nanomaterials
N. Knežević (2017)
10.1016/j.biomaterials.2015.04.006
Doxorubicin-loaded NaYF4:Yb/Tm-TiO2 inorganic photosensitizers for NIR-triggered photodynamic therapy and enhanced chemotherapy in drug-resistant breast cancers.
Leyong Zeng (2015)
10.1007/s40005-016-0297-1
Image-guided nanomedicine for cancer
J. Choi (2016)
10.1016/j.colsurfb.2019.04.023
Hierarchical bioresponsive nanocarriers for codelivery of curcumin and doxorubicin.
Jian-tao Lin (2019)
10.1002/9781118942246.CH4.3
Biocomposites from Nanoparticles
C. Aimé (2017)
10.1021/acsami.7b04742
Serum Protein Adsorption Enhances Active Leukemia Stem Cell Targeting of Mesoporous Silica Nanoparticles.
Michaela Beck (2017)
10.1002/advs.201600279
Nanoparticle Functionalization and Its Potentials for Molecular Imaging
R. Thiruppathi (2017)
10.1016/j.biologicals.2015.05.006
Antibody-drug conjugates for cancer therapy: The technological and regulatory challenges of developing drug-biologic hybrids.
G. S. Hamilton (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar